BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: An Z, Jiang P, Wang X, Moossa AR, Hoffman RM. Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection. Clin Exp Metastasis. 1999;17:265-270. [PMID: 10432012 DOI: 10.1023/a:1006654600095] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sobczuk P, Brodziak A, Khan MI, Chhabra S, Fiedorowicz M, Wełniak-Kamińska M, Synoradzki K, Bartnik E, Cudnoch-Jędrzejewska A, Czarnecka AM. Choosing The Right Animal Model for Renal Cancer Research. Transl Oncol 2020;13:100745. [PMID: 32092671 DOI: 10.1016/j.tranon.2020.100745] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
2 Sun YU, Nishino H, Zhao M, Miyake K, Sugisawa N, Yamamoto J, Tashiro Y, Inubushi S, Hamada K, Zhu G, Lim H, Hoffman RM. A Non-invasive Imageable GFP-expressing Mouse Model of Orthotopic Human Bladder Cancer. In Vivo 2020;34:3225-31. [PMID: 33144427 DOI: 10.21873/invivo.12158] [Reference Citation Analysis]
3 Rashid OM, Takabe K. Animal models for exploring the pharmacokinetics of breast cancer therapies. Expert Opin Drug Metab Toxicol 2015;11:221-30. [PMID: 25416501 DOI: 10.1517/17425255.2015.983073] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
4 Donat U, Rother J, Schäfer S, Hess M, Härtl B, Kober C, Langbein-Laugwitz J, Stritzker J, Chen NG, Aguilar RJ, Weibel S, Szalay AA. Characterization of metastasis formation and virotherapy in the human C33A cervical cancer model. PLoS One 2014;9:e98533. [PMID: 24887184 DOI: 10.1371/journal.pone.0098533] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tan X, He S, Han Y, Yu Y, Xiao J, Xu D, Wang G, Du Y, Chang W, Yin J, Su T, Hou J, Cao G. Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients. Cancer Cell Int 2013;13:20. [PMID: 23442546 DOI: 10.1186/1475-2867-13-20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
6 Illert B, Otto C, Thiede A, Timmermann W. Detection of disseminated tumor cells in nude mice with human gastric cancer. Clin Exp Metastasis 2003;20:549-54. [PMID: 14598889 DOI: 10.1023/a:1025862800798] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
7 Murphy EA, Majeti BK, Barnes LA, Makale M, Weis SM, Lutu-Fuga K, Wrasidlo W, Cheresh DA. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc Natl Acad Sci U S A 2008;105:9343-8. [PMID: 18607000 DOI: 10.1073/pnas.0803728105] [Cited by in Crossref: 326] [Cited by in F6Publishing: 295] [Article Influence: 25.1] [Reference Citation Analysis]
8 Longmire M, Kosaka N, Ogawa M, Choyke PL, Kobayashi H. Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer. Cancer Sci 2009;100:1099-104. [PMID: 19302283 DOI: 10.1111/j.1349-7006.2009.01133.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
9 Rashid OM, Nagahashi M, Ramachandran S, Dumur CI, Schaum JC, Yamada A, Aoyagi T, Milstien S, Spiegel S, Takabe K. Is tail vein injection a relevant breast cancer lung metastasis model? J Thorac Dis 2013;5:385-92. [PMID: 23991292 DOI: 10.3978/j.issn.2072-1439.2013.06.17] [Cited by in F6Publishing: 47] [Reference Citation Analysis]
10 Li Y, Li B, Xiang CP, Zhang Y, Li YY, Wu XL. Characterization of gastric cancer models from different cell lines orthotopically constructed using improved implantation techniques. World J Gastroenterol 2012; 18(2): 136-143 [PMID: 22253519 DOI: 10.3748/wjg.v18.i2.136] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
11 DeLong JC, Murakami T, Yazaki PJ, Hoffman RM, Bouvet M. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model. J Surg Res 2017;218:139-43. [PMID: 28985840 DOI: 10.1016/j.jss.2017.05.069] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
12 Igarashi K, Kawaguchi K, Kiyuna T, Murakami T, Miwa S, Nelson SD, Dry SM, Li Y, Singh A, Kimura H, Hayashi K, Yamamoto N, Tsuchiya H, Eilber FC, Hoffman RM. Patient-derived orthotopic xenograft (PDOX) mouse model of adult rhabdomyosarcoma invades and recurs after resection in contrast to the subcutaneous ectopic model. Cell Cycle 2017;16:91-4. [PMID: 27830986 DOI: 10.1080/15384101.2016.1252885] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
13 Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM, Arcaroli JJ, Messersmith WA, Eckhardt SG. Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol. 2012;9:338-350. [PMID: 22508028 DOI: 10.1038/nrclinonc.2012.61] [Cited by in Crossref: 773] [Cited by in F6Publishing: 694] [Article Influence: 85.9] [Reference Citation Analysis]
14 Valta MP, Zhao H, Ingels A, Thong AE, Nolley R, Saar M, Peehl DM. Development of a realistic in vivo bone metastasis model of human renal cell carcinoma. Clin Exp Metastasis 2014;31:573-84. [PMID: 24715498 DOI: 10.1007/s10585-014-9651-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
15 Li Y, Li B, Zhang Y, Xiang CP, Li YY, Wu XL. Serial observations on an orthotopic gastric cancer model constructed using improved implantation technique. World J Gastroenterol 2011; 17(11): 1442-1447 [PMID: 21472102 DOI: 10.3748/wjg.v17.i11.1442] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
16 Li L, Zhang L, Zhang X, Yan Q, Minamishima YA, Olumi AF, Mao M, Bartz S, Kaelin WG Jr. Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations. Mol Cell Biol 2007;27:5381-92. [PMID: 17526729 DOI: 10.1128/MCB.00282-07] [Cited by in Crossref: 76] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
17 An S, Tiruthani K, Wang Y, Xu L, Hu M, Li J, Song W, Jiang H, Sun J, Liu R, Huang L. Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection. Small 2019;15:e1805182. [PMID: 30690891 DOI: 10.1002/smll.201805182] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
18 Yoshida D, Teramoto A. The use of 3-D culture in peptide hydrogel for analysis of discoidin domain receptor 1-collagen interaction. Cell Adh Migr 2007;1:92-8. [PMID: 19262089 DOI: 10.4161/cam.1.2.4618] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zechmann CM, Woenne EC, Brix G, Radzwill N, Ilg M, Bachert P, Peschke P, Kirsch S, Kauczor HU, Delorme S, Semmler W, Kiessling F. Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors. Neoplasia 2007;9:57-67. [PMID: 17325744 DOI: 10.1593/neo.06688] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
20 Douglas ML, Boucaut KJ, Antalis TM, Higgins C, Pera MF, Stuttgen MA, Nicol DL. An orthotopic xenograft model of human nonseminomatous germ cell tumour. Br J Cancer 2001;85:608-11. [PMID: 11506503 DOI: 10.1054/bjoc.2001.1884] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
21 Chang XZ, Wang ZM, Yu JM, Tian FG, Jin W, Zhang Y, Yu J, Li LF, Liu XF, Li ZW, Shao ZM. Isolation of a human gallbladder cancer cell clone with high invasive phenotype in vitro and metastatic potential in orthotopic model and inhibition of its invasiveness by heparanase antisense oligodeoxynucleotides. Clin Exp Metastasis 2007;24:25-38. [PMID: 17260103 DOI: 10.1007/s10585-006-9053-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hiroshima Y, Maawy A, Zhang Y, Sato S, Murakami T, Yamamoto M, Uehara F, Miwa S, Yano S, Momiyama M, Chishima T, Tanaka K, Bouvet M, Endo I, Hoffman RM. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models. PLoS One 2014;9:e99977. [PMID: 24924955 DOI: 10.1371/journal.pone.0099977] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
23 Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 1999;17:343-59. [PMID: 10759402 DOI: 10.1023/a:1006326203858] [Cited by in Crossref: 396] [Cited by in F6Publishing: 204] [Article Influence: 18.9] [Reference Citation Analysis]
24 Wu J, Zhang Y, Frilot N, Kim JI, Kim WJ, Daaka Y. Prostaglandin E2 regulates renal cell carcinoma invasion through the EP4 receptor-Rap GTPase signal transduction pathway. J Biol Chem 2011;286:33954-62. [PMID: 21832044 DOI: 10.1074/jbc.M110.187344] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
25 Grisanzio C, Seeley A, Chang M, Collins M, Di Napoli A, Cheng SC, Percy A, Beroukhim R, Signoretti S. Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients. J Pathol 2011;225:212-21. [PMID: 21710693 DOI: 10.1002/path.2929] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
26 Paez-Ribes M, Man S, Xu P, Kerbel RS. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note. PLoS One 2016;11:e0158034. [PMID: 27355476 DOI: 10.1371/journal.pone.0158034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
27 Chintala S, Najrana T, Toth K, Cao S, Durrani FA, Pili R, Rustum YM. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition. BMC Cancer. 2012;12:293. [PMID: 22804960 DOI: 10.1186/1471-2407-12-293] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
28 Brodaczewska KK, Szczylik C, Fiedorowicz M, Porta C, Czarnecka AM. Choosing the right cell line for renal cell cancer research. Mol Cancer 2016;15:83. [PMID: 27993170 DOI: 10.1186/s12943-016-0565-8] [Cited by in Crossref: 106] [Cited by in F6Publishing: 94] [Article Influence: 21.2] [Reference Citation Analysis]
29 Rashidi B, Yang M, Jiang P, Baranov E, An Z, Wang X, Moossa AR, Hoffman RM. A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model. Clin Exp Metastasis 2000;18:57-60. [PMID: 11206839 DOI: 10.1023/a:1026596131504] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
30 Murphy EA, Shields DJ, Stoletov K, Dneprovskaia E, McElroy M, Greenberg JI, Lindquist J, Acevedo LM, Anand S, Majeti BK, Tsigelny I, Saldanha A, Walsh B, Hoffman RM, Bouvet M, Klemke RL, Vogt PK, Arnold L, Wrasidlo W, Cheresh DA. Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF. Proc Natl Acad Sci U S A 2010;107:4299-304. [PMID: 20154271 DOI: 10.1073/pnas.0909299107] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
31 Martiniova L, Schimel D, Lai EW, Limpuangthip A, Kvetnansky R, Pacak K. In vivo micro-CT imaging of liver lesions in small animal models. Methods 2010;50:20-5. [PMID: 19520168 DOI: 10.1016/j.ymeth.2009.05.016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
32 Deng YC, Zhen YS, Zheng S, Xue YC. Activity of boanmycin against colorectal cancer. World J Gastroenterol 2001; 7(1): 93-97 [PMID: 11819740 DOI: 10.3748/wjg.v7.i1.93] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]